BlackRock Institutional Trust’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14.3M Buy
1,135,790
+69,973
+7% +$1.3M ﹤0.01% 2189
2016
Q3
$29.9M Buy
1,065,817
+108,556
+11% +$3.64M ﹤0.01% 1610
2016
Q2
$33.5M Buy
957,261
+109,175
+13% +$3.43M 0.01% 1493
2016
Q1
$23.2M Sell
848,086
-6,831
-0.8% -$201K ﹤0.01% 1720
2015
Q4
$29.3M Buy
854,917
+20,608
+2% +$643K ﹤0.01% 1592
2015
Q3
$24M Buy
834,309
+160,414
+24% +$6.86M ﹤0.01% 1709
2015
Q2
$30.2M Buy
673,895
+345,273
+105% +$13M ﹤0.01% 1625
2015
Q1
$11.4M Buy
328,622
+117,101
+55% +$3.19M ﹤0.01% 2315
2014
Q4
$5.79M Buy
+211,521
New +$5.13M ﹤0.01% 2667

Other funds holding DPLO

BlackRock Institutional Trust's DPLO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 6.6% in Q4 2016, buying an estimated $1.3M and bringing the position to 1,135,790 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

BlackRock Institutional Trust first reported a position in DPLO in Q4 2014 and has held it in 9 quarters since. The position peaked at $33.5M in Q2 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • BlackRock Institutional Trust held 1,135,790 shares of DIPLOMAT PHARMACY, INC. worth $14.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 69,973 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $1.3M.
  • DIPLOMAT PHARMACY, INC. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2189 holding.
  • BlackRock Institutional Trust first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and has held it in 9 quarters since.
  • BlackRock Institutional Trust's DIPLOMAT PHARMACY, INC. position peaked at $33.5M in Q2 2016.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.